Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Neovascularization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07075835
What this trial is testing

Enhanced External Counterpulsation for Patients With Ventilation Disorders

Who this might be right for
Chronic Lung Diseases
I.M. Sechenov First Moscow State Medical University 80
Not applicableLooking for participantsNCT07298655
What this trial is testing

3D Contrast Enhanced Microvascular Ultrasound of Carotid Atherosclerosis for the Detection of Carotid Plaque Neo-Revascularisation.

Who this might be right for
Carotid AtherosclerosisUltrasoundPlaque Neovascularization
London North West Healthcare NHS Trust 10
Not applicableStudy completedNCT05969418
What this trial is testing

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Federico II University 50
Large-scale testing (Phase 3)Study completedNCT04278417
What this trial is testing

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Novartis Pharmaceuticals 689
Post-approval studies (Phase 4)Study completedNCT01628354
What this trial is testing

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
University of Melbourne 49
Large-scale testing (Phase 3)Looking for participantsNCT06497959
What this trial is testing

Study of Placental Vascularization Using Contrast Ultrasound

Who this might be right for
Fetal Growth Restriction
Central Hospital, Nancy, France 30
Early research (Phase 1)Ended earlyNCT01868360
What this trial is testing

Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea

Who this might be right for
Corneal Neovascularization
Balamurali Ambati 2
Early research (Phase 1)Study completedNCT02204683
What this trial is testing

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Macular Degeneration
University of Nebraska 5
Not applicableLooking for participantsNCT05700682
What this trial is testing

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

Who this might be right for
Osteoarthritis, KneeOsteoarthritis, HipOsteo Arthritis Shoulders+4 more
Palo Alto Veterans Institute for Research 120
Testing effectiveness (Phase 2)Study completedNCT00284089
What this trial is testing

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Novartis 88
Testing effectiveness (Phase 2)Study completedNCT03038880
What this trial is testing

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascularization, ChoroidalMacular Degeneration, Age-Related
Hoffmann-La Roche 76
Testing effectiveness (Phase 2)UnknownNCT02599064
What this trial is testing

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

Who this might be right for
Age-related Macular DegenerationSubfoveal Choroidal NeovascularizationSubretinal Scarring+1 more
RXi Pharmaceuticals, Corp. 9
Not applicableStudy completedNCT00919516
What this trial is testing

Autologous Bone Marrow Mononuclear Cell Implantation for Moderate to Severe Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
The Vascular and Vein Center, Columbus, OH 49
Not applicableUnknownNCT05130385
What this trial is testing

High Resolution Optical Coherence Tomography

Who this might be right for
Retinal DiseaseRetinal DetachmentRetinal Vein Occlusion+13 more
Insel Gruppe AG, University Hospital Bern 550
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Testing effectiveness (Phase 2)Study completedNCT01037348
What this trial is testing

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

Who this might be right for
Choroidal Neovascularisation
Novartis 65
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT01810042
What this trial is testing

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Pusan National University Hospital 49
Next Page